NCT06625229 is a clinical trial in Hallux Valgus Deformity, sponsored by Orthopaedic and Arthritis Specialist Centre.

Who is sponsoring NCT06625229?

NCT06625229 is sponsored by Orthopaedic and Arthritis Specialist Centre.

What condition does NCT06625229 study?

NCT06625229 studies Hallux Valgus Deformity, Hallux Valgus (Bunion) Resection, Hallux Valgus Surgery, Hallux Deformity, Forefoot Surgery, Minimally Invasive Surgical Procedures, Minimally Invasive Surgical Technique, Hallux Abductovalgus.

Is NCT06625229 still recruiting?

NCT06625229 is currently completed. Last updated 3 October 2024.

Last reviewed 2024-10-03 · How we verify

NCT06625229

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fourth Generation Percutaneous Transverse Osteotomies for Hallux Valgus

Completed Last updated 3 October 2024

What this trial tests

trial in Hallux Valgus Deformity in 483 participants. Completed in 31 August 2023.

Timeline

1 November 2017

Primary endpoint
31 January 2023

31 August 2023

Quick facts

Lead sponsor	Orthopaedic and Arthritis Specialist Centre
Status	Completed
Study type	OBSERVATIONAL
Enrollment	483
Start date	1 November 2017
Primary completion	31 January 2023
Estimated completion	31 August 2023
Sites	1 location across Australia

Conditions studied

Hallux Valgus Deformity — all drugs for Hallux Valgus Deformity →
Hallux Valgus (Bunion) Resection — all drugs for Hallux Valgus (Bunion) Resection →
Hallux Valgus Surgery — all drugs for Hallux Valgus Surgery →
Hallux Deformity — all drugs for Hallux Deformity →

Sponsor

Orthopaedic and Arthritis Specialist Centre

Who can join

16 and older, any sex, with Hallux Valgus Deformity or Hallux Valgus (Bunion) Resection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this observational study is to learn if percutaneous transverse osteotomies for hallux valgus deformity are safe and effective. The main questions it aims to answer are: 1. What is the change in clinical patient reported outcome measures after minimally invasive bunion surgery 2. What severity of bunion deformity can be corrected with minimally invasive surgery 3. What factors may lead to recurrence of bunion deformity 4. What is the rate of complications following bunion deformity surgery Researchers will retrospectively review a research registry containing prospectively collected clinical and radiographic deformity data collected as part of routine care.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Fourth-Generation Percutaneous Transverse Osteotomies for Hallux Valgus.
Lam P, Murphy EP, Chua MJ, Ray R, et al · · 2025 · cited 3× · PMID 40854004 · DOI 10.2106/jbjs.24.01326

Verify or expand the search:

Other recruiting trials for Hallux Valgus Deformity

Currently open trials in the same condition.

NCT07344077 — Comparing Outcomes Using 1 Versus 2 Kirshner Wire Fixation in Patients With Severe Hallux Valgus · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06625229 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Orthopaedic and Arthritis Specialist Centre
Last refreshed: 3 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06625229.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing